Notice: This company has been marked as potentially delisted and may not be actively trading. Neurotrope (NTRP) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsShort InterestTrendsBuy This Stock NTRP vs. MODV, YGMZ, MOND, BKNG, EXPE, XPO, MMYT, GATX, GXO, and GBTGShould you be buying Neurotrope stock or one of its competitors? The main competitors of Neurotrope include ModivCare (MODV), MingZhu Logistics (YGMZ), Mondee (MOND), Booking (BKNG), Expedia Group (EXPE), XPO (XPO), MakeMyTrip (MMYT), GATX (GATX), GXO Logistics (GXO), and Global Business Travel Group (GBTG). These companies are all part of the "transportation services" industry. Neurotrope vs. ModivCare MingZhu Logistics Mondee Booking Expedia Group XPO MakeMyTrip GATX GXO Logistics Global Business Travel Group Neurotrope (NASDAQ:NTRP) and ModivCare (NASDAQ:MODV) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, community ranking, profitability, media sentiment, analyst recommendations, risk and institutional ownership. Is NTRP or MODV more profitable? Neurotrope has a net margin of 0.00% compared to ModivCare's net margin of -6.57%. ModivCare's return on equity of 26.14% beat Neurotrope's return on equity.Company Net Margins Return on Equity Return on Assets NeurotropeN/A -806.36% -112.57% ModivCare -6.57%26.14%1.08% Do analysts prefer NTRP or MODV? Neurotrope currently has a consensus price target of $5.00, indicating a potential downside of 9.58%. ModivCare has a consensus price target of $8.38, indicating a potential upside of 502.52%. Given ModivCare's stronger consensus rating and higher probable upside, analysts clearly believe ModivCare is more favorable than Neurotrope.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neurotrope 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00ModivCare 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals and insiders hold more shares of NTRP or MODV? 3.8% of Neurotrope shares are held by institutional investors. 8.4% of Neurotrope shares are held by company insiders. Comparatively, 1.2% of ModivCare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has stronger valuation and earnings, NTRP or MODV? Neurotrope has higher earnings, but lower revenue than ModivCare. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeurotrope$630K13.96N/AN/AN/AModivCare$2.79B0.01-$204.46M-$14.15-0.10 Does the media refer more to NTRP or MODV? In the previous week, ModivCare had 31 more articles in the media than Neurotrope. MarketBeat recorded 32 mentions for ModivCare and 1 mentions for Neurotrope. ModivCare's average media sentiment score of 0.07 beat Neurotrope's score of 0.00 indicating that ModivCare is being referred to more favorably in the news media. Company Overall Sentiment Neurotrope Neutral ModivCare Neutral Does the MarketBeat Community believe in NTRP or MODV? Neurotrope received 157 more outperform votes than ModivCare when rated by MarketBeat users. Likewise, 63.16% of users gave Neurotrope an outperform vote while only 48.94% of users gave ModivCare an outperform vote. CompanyUnderperformOutperformNeurotropeOutperform Votes18063.16% Underperform Votes10536.84% ModivCareOutperform Votes2348.94% Underperform Votes2451.06% Which has more risk & volatility, NTRP or MODV? Neurotrope has a beta of 1.69, meaning that its stock price is 69% more volatile than the S&P 500. Comparatively, ModivCare has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. SummaryModivCare beats Neurotrope on 8 of the 15 factors compared between the two stocks. Remove Ads Get Neurotrope News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRP vs. The Competition Export to ExcelMetricNeurotropeTransportation services IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$8.79M$11.33B$7.58B$7.84BDividend YieldN/A4.54%2.98%4.01%P/E RatioN/A17.2916.5918.74Price / Sales13.962.619.7390.77Price / CashN/A25.8516.4234.64Price / Book1.663.254.254.23Net IncomeN/A$467.60M$261.74M$247.47M Neurotrope Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRPNeurotrope0.466 of 5 stars$5.53-2.5%$5.00-9.6%+22.6%$8.79M$630,000.000.005Gap DownMODVModivCare4.0236 of 5 stars$1.94-8.5%$8.38+331.7%-94.1%$27.82M$2.79B-0.1520,200Short Interest ↑High Trading VolumeYGMZMingZhu Logistics0.8962 of 5 stars$0.86-3.9%N/A-75.7%$4.13M$55.81M0.0080MONDMondee1.1829 of 5 starsN/A$3.83+∞N/A$87,000.00$232.97M0.001,226BKNGBooking4.4393 of 5 stars$4,709.72+2.0%$5,370.43+14.0%+27.7%$154.55B$23.74B27.2224,300Analyst UpgradePositive NewsEXPEExpedia Group4.8463 of 5 stars$178.29+2.6%$193.43+8.5%+22.0%$22.97B$13.69B19.7016,500Gap UpXPOXPO4.5234 of 5 stars$112.64+3.7%$158.47+40.7%-12.0%$13.21B$8.07B34.8723,000Analyst ForecastBuyback AnnouncementGap DownMMYTMakeMyTrip2.7004 of 5 stars$107.02+5.9%$122.50+14.5%+45.7%$11.75B$935.76M58.164,576Positive NewsGATXGATX2.1141 of 5 stars$158.00+2.0%$161.00+1.9%+16.3%$5.64B$1.59B20.341,900News CoverageGXOGXO Logistics3.5018 of 5 stars$40.55+0.4%$55.60+37.1%-26.8%$4.85B$11.71B36.20131,000Positive NewsGBTGGlobal Business Travel Group2.689 of 5 stars$7.70+1.1%$9.90+28.7%+22.4%$3.68B$2.42B-21.3819,000Positive News Remove Ads Related Companies and Tools Related Companies ModivCare Alternatives MingZhu Logistics Alternatives Mondee Alternatives Booking Alternatives Expedia Group Alternatives XPO Alternatives MakeMyTrip Alternatives GATX Alternatives GXO Logistics Alternatives Global Business Travel Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NTRP) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotrope, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurotrope With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NTRP Stock Free NTRP Stock Alerts